The detection of middle exons (exons five-six) showed a nonsignificant decrease in ANRIL expression in the premature CAD group compared with the non-CAD group (Fig. 2D), while the detection of terminal exons manifested a significant downregulation (Fig. 2A,G). The gene discussed is CDKN2B-AS1; the disease is coronary artery disorder.